All Type of News
Vita 500 remains popular in beverage market
Dong-A Pharmaceutical, Korea’s largest drug manufacturer in terms of sales, saw the sales of Bacchus energy drinks increase 17 percent on-year in 2011, to 150.1 billion won as Bacchus was reclassified into “quasi-drug...
Major drug wholesalers face probe over irregular bidding in hospital
A joint government investigation team will embark on scrutinizing the country's eight major hospitals in relation to undue business practices involving hospital tenders, following its investigation into the drug maker...
Ultrasound contrast agent Sonazoid for Injection released for sale
GE Healthcare Korea said today that it has rolled out the ultrasound contrast agent Sonazoid for Injection, which has been marketed in Japan since 2007.
Sonazoid for injection was developed jointly by Daiichi Pharm...
Korea’s ED drug market volumes to surge
As the main patent for Viagra, the world’s bestselling anti-impotence pill, nears its expiration, the Korean erectile dysfunction market is estimated to rapidly grow 150 billion won with many Viagra generic products c...
Bacchus sales face setback
Dong-A Pharmaceutical enjoyed a spike in sales after Bacchus hit supermarkets’ shelves across Korea, posting record revenue of 46.7 billion won in the third quarter of last year due to the gradual fading of speculativ...
DMF registration and prior drug review systems to be eyed
Drug manufacturers are obliged to register pharmaceutical raw materials in accordance with new DMF (drug master file) registration system. In addition, the government will implement a prior review system of new drugs ...
Drug’s permission renewal to be made compulsory
The state-run drug regulator plans to complete the approval process determining the terms of the drug’s permission renewal, which will come five years after being put to market.
Under the recently revised bill, th...
SK Chemicals conduct 10 phase I trials
SK Chemicals has sponsored 10 phase-1 clinical trials, the highest in Korea’s leading pharmaceutical firms, heralding the potential outcome in the development of new drugs, according to the industrial sources.
The ...
Drug makers expect worse business conditions in 2nd quarter
Korean pharmaceutical companies expect market connditions to be further sluggish over the next three months, according to industry officials.
Korea’s major pharmaceutical firms saw their earnings decline 43 percent...
Health Ministry dismisses reports on nonpharmacy sales
The Ministry of Health and Welfare on Wednesday dismissed recent reports of alleged nonpharmacy sales of nasal refreshers, sex lubricants and cosmetics for treatment of atopic dermatitis, saying no one has any concret...
